Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant

Ae Park Shin, Sun Song Eun, Je Cho Yang, Young Ahn Bo, Suk Hoon Ha, Lin Seong Bak, Hee Lee Kwang, Gyong Lee Na

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

CIA07 is an immunostimulatory agent composed of E. coli DNA fragments and modified LPS lacking the lipid A moiety. In this study, we investigated whether CIA07 promotes immune responses as an adjuvant to the influenza subunit vaccine. Balb/c mice were immunized intramuscularly once or twice at a 4-week interval with the trivalent influenza subunit vaccine antigen alone or in combination with CIA07 as adjuvant. Antigen-specific serum antibody titers and hemagglutination-inhibition (HI) antibody titers were assessed. At 4 weeks after each immunization, the antigen-specific total serum IgG antibody titer in mice receiving CIA07 was 2 to 3 times higher than that in animals administered antigen alone (P<0.05). The CIA07-treated group additionally displayed higher HI antibody titers against each of the 3 vaccine strains, compared to the antigen group. Animals receiving antigen alone displayed barely detectable antigen-specific serum IgG2a antibody titers. In contrast, coadministration of CIA07 with antigen led to significantly enhanced IgG2a antibody responses, suggesting that CIA07 stimulates a Th1-type immune response. Moreover, the CIA07-treated group displayed a marked increase in the number of interferon γ-producing CD8+ T cells in splenocytes. These data collectively demonstrate that CIA07 has the ability to induce both Th1-type cellular and Th2-type humoral immune responses to the influenza subunit vaccine, and support its potential as an effective adjuvant to the influenza vaccine.

Original languageEnglish
Pages (from-to)1099-1107
Number of pages9
JournalMicrobiology and Immunology
Volume51
Issue number11
Publication statusPublished - 2007 Nov 27

Fingerprint

Subunit Vaccines
Influenza Vaccines
Antigens
Antibodies
Hemagglutination
Serum
Lipid A
CIA07 adjuvant
Humoral Immunity
Interferons
Antibody Formation
Immunization
Vaccines
Immunoglobulin G
Escherichia coli
T-Lymphocytes
DNA

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Virology

Cite this

Shin, A. P., Eun, S. S., Yang, J. C., Bo, Y. A., Ha, S. H., Bak, L. S., ... Na, G. L. (2007). Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant. Microbiology and Immunology, 51(11), 1099-1107.
Shin, Ae Park ; Eun, Sun Song ; Yang, Je Cho ; Bo, Young Ahn ; Ha, Suk Hoon ; Bak, Lin Seong ; Kwang, Hee Lee ; Na, Gyong Lee. / Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant. In: Microbiology and Immunology. 2007 ; Vol. 51, No. 11. pp. 1099-1107.
@article{9d8eaa83cdd64338ab71a9b1c35865ff,
title = "Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant",
abstract = "CIA07 is an immunostimulatory agent composed of E. coli DNA fragments and modified LPS lacking the lipid A moiety. In this study, we investigated whether CIA07 promotes immune responses as an adjuvant to the influenza subunit vaccine. Balb/c mice were immunized intramuscularly once or twice at a 4-week interval with the trivalent influenza subunit vaccine antigen alone or in combination with CIA07 as adjuvant. Antigen-specific serum antibody titers and hemagglutination-inhibition (HI) antibody titers were assessed. At 4 weeks after each immunization, the antigen-specific total serum IgG antibody titer in mice receiving CIA07 was 2 to 3 times higher than that in animals administered antigen alone (P<0.05). The CIA07-treated group additionally displayed higher HI antibody titers against each of the 3 vaccine strains, compared to the antigen group. Animals receiving antigen alone displayed barely detectable antigen-specific serum IgG2a antibody titers. In contrast, coadministration of CIA07 with antigen led to significantly enhanced IgG2a antibody responses, suggesting that CIA07 stimulates a Th1-type immune response. Moreover, the CIA07-treated group displayed a marked increase in the number of interferon γ-producing CD8+ T cells in splenocytes. These data collectively demonstrate that CIA07 has the ability to induce both Th1-type cellular and Th2-type humoral immune responses to the influenza subunit vaccine, and support its potential as an effective adjuvant to the influenza vaccine.",
author = "Shin, {Ae Park} and Eun, {Sun Song} and Yang, {Je Cho} and Bo, {Young Ahn} and Ha, {Suk Hoon} and Bak, {Lin Seong} and Kwang, {Hee Lee} and Na, {Gyong Lee}",
year = "2007",
month = "11",
day = "27",
language = "English",
volume = "51",
pages = "1099--1107",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "11",

}

Shin, AP, Eun, SS, Yang, JC, Bo, YA, Ha, SH, Bak, LS, Kwang, HL & Na, GL 2007, 'Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant', Microbiology and Immunology, vol. 51, no. 11, pp. 1099-1107.

Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant. / Shin, Ae Park; Eun, Sun Song; Yang, Je Cho; Bo, Young Ahn; Ha, Suk Hoon; Bak, Lin Seong; Kwang, Hee Lee; Na, Gyong Lee.

In: Microbiology and Immunology, Vol. 51, No. 11, 27.11.2007, p. 1099-1107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant

AU - Shin, Ae Park

AU - Eun, Sun Song

AU - Yang, Je Cho

AU - Bo, Young Ahn

AU - Ha, Suk Hoon

AU - Bak, Lin Seong

AU - Kwang, Hee Lee

AU - Na, Gyong Lee

PY - 2007/11/27

Y1 - 2007/11/27

N2 - CIA07 is an immunostimulatory agent composed of E. coli DNA fragments and modified LPS lacking the lipid A moiety. In this study, we investigated whether CIA07 promotes immune responses as an adjuvant to the influenza subunit vaccine. Balb/c mice were immunized intramuscularly once or twice at a 4-week interval with the trivalent influenza subunit vaccine antigen alone or in combination with CIA07 as adjuvant. Antigen-specific serum antibody titers and hemagglutination-inhibition (HI) antibody titers were assessed. At 4 weeks after each immunization, the antigen-specific total serum IgG antibody titer in mice receiving CIA07 was 2 to 3 times higher than that in animals administered antigen alone (P<0.05). The CIA07-treated group additionally displayed higher HI antibody titers against each of the 3 vaccine strains, compared to the antigen group. Animals receiving antigen alone displayed barely detectable antigen-specific serum IgG2a antibody titers. In contrast, coadministration of CIA07 with antigen led to significantly enhanced IgG2a antibody responses, suggesting that CIA07 stimulates a Th1-type immune response. Moreover, the CIA07-treated group displayed a marked increase in the number of interferon γ-producing CD8+ T cells in splenocytes. These data collectively demonstrate that CIA07 has the ability to induce both Th1-type cellular and Th2-type humoral immune responses to the influenza subunit vaccine, and support its potential as an effective adjuvant to the influenza vaccine.

AB - CIA07 is an immunostimulatory agent composed of E. coli DNA fragments and modified LPS lacking the lipid A moiety. In this study, we investigated whether CIA07 promotes immune responses as an adjuvant to the influenza subunit vaccine. Balb/c mice were immunized intramuscularly once or twice at a 4-week interval with the trivalent influenza subunit vaccine antigen alone or in combination with CIA07 as adjuvant. Antigen-specific serum antibody titers and hemagglutination-inhibition (HI) antibody titers were assessed. At 4 weeks after each immunization, the antigen-specific total serum IgG antibody titer in mice receiving CIA07 was 2 to 3 times higher than that in animals administered antigen alone (P<0.05). The CIA07-treated group additionally displayed higher HI antibody titers against each of the 3 vaccine strains, compared to the antigen group. Animals receiving antigen alone displayed barely detectable antigen-specific serum IgG2a antibody titers. In contrast, coadministration of CIA07 with antigen led to significantly enhanced IgG2a antibody responses, suggesting that CIA07 stimulates a Th1-type immune response. Moreover, the CIA07-treated group displayed a marked increase in the number of interferon γ-producing CD8+ T cells in splenocytes. These data collectively demonstrate that CIA07 has the ability to induce both Th1-type cellular and Th2-type humoral immune responses to the influenza subunit vaccine, and support its potential as an effective adjuvant to the influenza vaccine.

UR - http://www.scopus.com/inward/record.url?scp=36349023947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36349023947&partnerID=8YFLogxK

M3 - Article

C2 - 18037787

AN - SCOPUS:36349023947

VL - 51

SP - 1099

EP - 1107

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 11

ER -